THE PHARMACOGENOMICS OF EGFR-DEPENDENT NSCLC: PREDICTING AND ENHANCING RESPONSE TO TARGETED EGFR THERAPY

by Balko, Justin M.
Published 2009

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

by Black Esther P, Balko Justin M
Published 2009-05-01

Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors

by Haura Eric B, Stromberg Arnold, Saunders Christopher, Potti Anil, Balko Justin M, Black Esther P
Published 2006-11-01